Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MIST

Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MIST
DateTimeSourceHeadlineSymbolCompany
01/07/20257:00AMGlobeNewswire Inc.Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MISTMilestone Pharmaceuticals Inc
11/24/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MISTMilestone Pharmaceuticals Inc
11/12/20243:38PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MISTMilestone Pharmaceuticals Inc
11/12/20243:36PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MISTMilestone Pharmaceuticals Inc
11/12/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
11/12/20246:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
09/04/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/29/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/08/20243:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
08/08/20243:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
07/17/20243:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
07/17/20243:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
07/17/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
07/17/20243:15PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
07/16/20245:06PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MISTMilestone Pharmaceuticals Inc
07/15/20243:41PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MISTMilestone Pharmaceuticals Inc
07/15/20243:38PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
07/15/20243:36PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
07/15/20243:34PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MISTMilestone Pharmaceuticals Inc
07/15/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
05/29/20246:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
05/22/20247:00AMGlobeNewswire Inc.Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT AwarenessNASDAQ:MISTMilestone Pharmaceuticals Inc
05/13/20246:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
05/13/20245:59AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
03/04/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MIST